Actively Recruiting
Biomarkers and Cardiac CT
Led by Maastricht University Medical Center · Updated on 2017-03-28
5000
Participants Needed
1
Research Sites
773 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Coronary artery disease (CAD) is the leading cause of morbidity and mortality in developed countries. In addition, many patients suffer from valvular and aortic disease. Although various tools are available to identify patients with cardiovascular (CV) disease at risk for major adverse cardiac events (MACE), the identification of these patients remains a clinical challenge. One promising avenue is the use of different serum biomarkers involved in atherothrombosis which could provide an easy and cost-effective step in risk stratification.
CONDITIONS
Official Title
Biomarkers and Cardiac CT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients referred from the Cardiology clinic for routine CCTA.
You will not qualify if you...
- Pregnancy
- Severe renal insufficiency
- Severe allergy to contrast medium
- Inability to obtain informed consent
- Age below 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maastricht University Medical Center
Maastricht, Limburg, Netherlands, 6202AZ
Actively Recruiting
Research Team
B
Bas Kietselaer, MD, PhD
CONTACT
S
Sibel Altintas, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here